Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Advising N+1 Singer on £25 million placing to drive digital transformation of healthcare systems

14 juin 2021

par Ross McNaughton

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Revolutionising access to biology with transformational acquisition by Nuclera

13 mai 2021

par Ross McNaughton et Adrian Toutoungi

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

US and UK national security and investment – a joint discussion with CFIUS and BEIS

11 mai 2021

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Advising leading-edge life sciences companies on transformational roll-up and $114m crossover financing

10 mars 2021

par Ross McNaughton et Richard Faichney

Cliquer ici pour en savoir plus